Company / Free Cash Flow
CHAMPIONS ONCOLOGY, INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$7.0M
FY2025
5-year range
-$7.0M / $7.0M
FY2021-FY2025
Trend
-199.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 10 years, ranging from -$10M in FY2016 to $7M in FY2024.
Based on SEC 10-K filings.
-$7M in FY2025.
Declined from $4M to -$7M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow decreased 199.7% year-over-year.
- Peak free cash flow was recorded in FY2024.
- Lowest free cash flow in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.0M | -199.7% |
| FY2024 | $7.0M | +70.1% |
| FY2023 | $4.1M | +182.9% |
| FY2022 | -$5.0M | -824.4% |
| FY2021 | $685.0K | +113.8% |
| FY2020 | -$5.0M | -824.4% |
| FY2019 | $685.0K | +119.0% |
| FY2018 | -$3.6M | +46.4% |
| FY2017 | -$6.7M | +31.0% |
| FY2016 | -$9.7M | -165.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026